Product Images Quetiapine Fumarate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Quetiapine Fumarate NDC 47335-903 by Sun Pharmaceutical Industries, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

100 mg

100 mg

The text is a medication label for Quetiapine tablets. It includes the National Drug Code (NDC), dosage information (100 tablets), and instructions for pharmacists to dispense the medication guide to each patient.*

200 mg

200 mg

This is a medication guide for Quetiapine tablets containing 10-200 mg of quetiapine fumarate. The suitable dosage is recommended in the accompanying prescribing information. It is important to store the medication at a temperature range of 20°C to 25°C and not to allow children to reach it. The medication guide can be obtained via a link mentioned in the text. Pharmacist must dispense the medication guide to each patient. The manufacturer is Sun Pharmaceutical Industries Ltd with an address in India, and the distributor is Sun Pharmaceutical Industries, Inc. However, there is a typo in the company's name as "Phamaceutical".*

25mg - 25mg

25mg - 25mg

This is a label for Quetiapine Tablets, USP with an NDC number of 47335-902-88. The pharmacist is instructed to dispense medication with a guide for each patient. The label contains the prescription information, including that it is RX only and there are 100 tablets. There is also a code at the bottom of the label: DNH/DRUGS/NH/138 PGLB0609D.*

300 mg

300 mg

Each film-coated tablet contains 300 mg of quetiapine fumarate, USP. It is recommended to refer to the accompanying Prescribing Information for the usual dosage. The medication should be kept out of the reach of children and stored at controlled room temperature. A medication guide is available at an indicated website. The product is distributed by Sun Pharmaceutical Industries, Inc. and manufactured by Sun Pharmaceutical Industries Ltd. The NDC number is 47335-906-88. Pharmacists are advised to dispense medication with a guide to each patient.*

400 mg

400 mg

Each tablet contains 400 mg of quetiapine fumarate. Dosage instructions are available in the accompanying Prescribing Information. Keep out of reach of children. Store between 20° to 25°C (68° to 77°F); excursions permitted between 15° and 30°C (59° and 86°F). The Medication Guide can be found at 'https://www.sunpharma.convusa/products'. The tablets are dispensed with a Medication Guide to each patient. This drug is available only with a prescription. The tablets are distributed by Sun Pharmaceutical Industries, Inc. They are manufactured by Sun Pharmaceutical Industries Ltd. located in India.*

50 mg

50 mg

This is a label for Quetiapine Tablets, USP with a strength of 50 mg, which is available in a bottle containing 100 tablets. The pharmacist is advised to dispense the tablets with a Medication Guide to each patient. It is available only with a prescription and the NDC code is 47335-903-88. The remaining text cannot be evaluated as it contains non-English characters and appears to be a product code.*

quetiapine-fig-1 - quetiapine fig 1

quetiapine-fig-1 - quetiapine fig 1

The text describes a figure (Figure 1) that illustrates Kaplan-Meier curves showing the time to recurrence of a mood event in a study labeled as Study 7. The graph shows the proportion of patients experiencing relapse with percentages on the y-axis and the time in weeks on the x-axis. Two treatments are compared: QTP + LIVAL and PLA+LIVAL, with the former showing a lower proportion of patients experiencing relapse over time.*

quetiapine-fig-2 - quetiapine fig 2

quetiapine-fig-2 - quetiapine fig 2

The image is a Kaplan-Meier curve illustrating the time to recurrence of a mood event in Study 8. The x-axis represents time in weeks, while the y-axis represents the proportion of patients with relapse. There are two curves displayed, one for patients treated with QTP+LIVAL and one for patients treated with PLA+LIVAL. The proportion of patients with relapse is higher in the PLA+LIVAL group.*

quetiapine-structure - quetiapine structure

quetiapine-structure - quetiapine structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.